NGUYEN ALEXANDER HIEU (See Remarks) sold 8.0% of their position (1.95K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/31/2025ACC: 0000950170-25-047761
Officer· See Remarks
Since Mar 2021
+115.05K
Net shares
Net buyer
$2.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
117K acquired · 1.95K disposed
Non-Derivative Transactions2
Common Stock, $0.0001 par value
Direct
Shares
−1.95K
Price / share
$1.16
Trade value
$2.27K
% of position
8.0%
3/27/2025
24.56K→22.61K
Common Stock, $0.0001 par value
Direct
Shares
+44K
Price / share
—
Trade value
—
% of position
194.6%
3/28/2025
22.61K→66.61K
Total
Net shares
+42.05K
Net value
-$2.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 3/27/2025 | S · Sale | −1.95K | $1.16 | $2.27K | 8.0% | 24.56K | 22.61K |
| Common Stock, $0.0001 par value Direct | 3/28/2025 | A · Award | +44K | — | — | 194.6% | 22.61K | 66.61K |
| Total | +42.05K | -$2.27K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
73K shares
Shares
+73K
Strike price
1.67
Held after
73K
Exercisable
—
3/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock73K shares | 3/28/2025 | A · Award | +73K | 1.67 | — | 73K |